Home/Filings/4/0000899243-20-016898
4//SEC Filing

Green Park & Golf Ventures II, LLC 4

Accession 0000899243-20-016898

CIK 0001763950other

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 5:35 PM ET

Size

31.5 KB

Accession

0000899243-20-016898

Insider Transaction Report

Form 4
Period: 2020-06-15
Transactions
  • Conversion

    Series A Preferred Stock, par value $0.01

    2020-06-15168,1640 total(indirect: See footnote)
    Common Stock (292,605 underlying)
  • Conversion

    Common Stock, par value $0.0001

    2020-06-15+131,697131,697 total(indirect: See footnote)
  • Conversion

    Common Stock, par value $0.0001

    2020-06-15+41,535211,291 total(indirect: See footnote)
  • Conversion

    Series A Preferred Stock, par value $0.01

    2020-06-1523,8710 total(indirect: See footnote)
    Common Stock (41,535 underlying)
  • Conversion

    Common Stock, par value $0.0001

    2020-06-15+292,605292,605 total(indirect: See footnote)
  • Conversion

    Series A Preferred Stock, par value $0.01

    2020-06-1675,6880 total(indirect: See footnote)
    Common Stock (131,697 underlying)
Transactions
  • Conversion

    Series A Preferred Stock, par value $0.01

    2020-06-1675,6880 total(indirect: See footnote)
    Common Stock (131,697 underlying)
  • Conversion

    Common Stock, par value $0.0001

    2020-06-15+292,605292,605 total(indirect: See footnote)
  • Conversion

    Series A Preferred Stock, par value $0.01

    2020-06-15168,1640 total(indirect: See footnote)
    Common Stock (292,605 underlying)
  • Conversion

    Common Stock, par value $0.0001

    2020-06-15+41,535211,291 total(indirect: See footnote)
  • Conversion

    Common Stock, par value $0.0001

    2020-06-15+131,697131,697 total(indirect: See footnote)
  • Conversion

    Series A Preferred Stock, par value $0.01

    2020-06-1523,8710 total(indirect: See footnote)
    Common Stock (41,535 underlying)
Transactions
  • Conversion

    Common Stock, par value $0.0001

    2020-06-15+41,535211,291 total(indirect: See footnote)
  • Conversion

    Common Stock, par value $0.0001

    2020-06-15+292,605292,605 total(indirect: See footnote)
  • Conversion

    Series A Preferred Stock, par value $0.01

    2020-06-1523,8710 total(indirect: See footnote)
    Common Stock (41,535 underlying)
  • Conversion

    Common Stock, par value $0.0001

    2020-06-15+131,697131,697 total(indirect: See footnote)
  • Conversion

    Series A Preferred Stock, par value $0.01

    2020-06-1675,6880 total(indirect: See footnote)
    Common Stock (131,697 underlying)
  • Conversion

    Series A Preferred Stock, par value $0.01

    2020-06-15168,1640 total(indirect: See footnote)
    Common Stock (292,605 underlying)
Transactions
  • Conversion

    Series A Preferred Stock, par value $0.01

    2020-06-1523,8710 total(indirect: See footnote)
    Common Stock (41,535 underlying)
  • Conversion

    Series A Preferred Stock, par value $0.01

    2020-06-1675,6880 total(indirect: See footnote)
    Common Stock (131,697 underlying)
  • Conversion

    Common Stock, par value $0.0001

    2020-06-15+41,535211,291 total(indirect: See footnote)
  • Conversion

    Common Stock, par value $0.0001

    2020-06-15+292,605292,605 total(indirect: See footnote)
  • Conversion

    Common Stock, par value $0.0001

    2020-06-15+131,697131,697 total(indirect: See footnote)
  • Conversion

    Series A Preferred Stock, par value $0.01

    2020-06-15168,1640 total(indirect: See footnote)
    Common Stock (292,605 underlying)
Transactions
  • Conversion

    Common Stock, par value $0.0001

    2020-06-15+41,535211,291 total(indirect: See footnote)
  • Conversion

    Common Stock, par value $0.0001

    2020-06-15+292,605292,605 total(indirect: See footnote)
  • Conversion

    Common Stock, par value $0.0001

    2020-06-15+131,697131,697 total(indirect: See footnote)
  • Conversion

    Series A Preferred Stock, par value $0.01

    2020-06-1523,8710 total(indirect: See footnote)
    Common Stock (41,535 underlying)
  • Conversion

    Series A Preferred Stock, par value $0.01

    2020-06-15168,1640 total(indirect: See footnote)
    Common Stock (292,605 underlying)
  • Conversion

    Series A Preferred Stock, par value $0.01

    2020-06-1675,6880 total(indirect: See footnote)
    Common Stock (131,697 underlying)
Transactions
  • Conversion

    Common Stock, par value $0.0001

    2020-06-15+131,697131,697 total(indirect: See footnote)
  • Conversion

    Series A Preferred Stock, par value $0.01

    2020-06-15168,1640 total(indirect: See footnote)
    Common Stock (292,605 underlying)
  • Conversion

    Common Stock, par value $0.0001

    2020-06-15+292,605292,605 total(indirect: See footnote)
  • Conversion

    Series A Preferred Stock, par value $0.01

    2020-06-1675,6880 total(indirect: See footnote)
    Common Stock (131,697 underlying)
  • Conversion

    Common Stock, par value $0.0001

    2020-06-15+41,535211,291 total(indirect: See footnote)
  • Conversion

    Series A Preferred Stock, par value $0.01

    2020-06-1523,8710 total(indirect: See footnote)
    Common Stock (41,535 underlying)
Transactions
  • Conversion

    Series A Preferred Stock, par value $0.01

    2020-06-1523,8710 total(indirect: See footnote)
    Common Stock (41,535 underlying)
  • Conversion

    Common Stock, par value $0.0001

    2020-06-15+41,535211,291 total(indirect: See footnote)
  • Conversion

    Series A Preferred Stock, par value $0.01

    2020-06-15168,1640 total(indirect: See footnote)
    Common Stock (292,605 underlying)
  • Conversion

    Common Stock, par value $0.0001

    2020-06-15+131,697131,697 total(indirect: See footnote)
  • Conversion

    Common Stock, par value $0.0001

    2020-06-15+292,605292,605 total(indirect: See footnote)
  • Conversion

    Series A Preferred Stock, par value $0.01

    2020-06-1675,6880 total(indirect: See footnote)
    Common Stock (131,697 underlying)
Transactions
  • Conversion

    Common Stock, par value $0.0001

    2020-06-15+41,535211,291 total(indirect: See footnote)
  • Conversion

    Series A Preferred Stock, par value $0.01

    2020-06-15168,1640 total(indirect: See footnote)
    Common Stock (292,605 underlying)
  • Conversion

    Common Stock, par value $0.0001

    2020-06-15+131,697131,697 total(indirect: See footnote)
  • Conversion

    Series A Preferred Stock, par value $0.01

    2020-06-1675,6880 total(indirect: See footnote)
    Common Stock (131,697 underlying)
  • Conversion

    Common Stock, par value $0.0001

    2020-06-15+292,605292,605 total(indirect: See footnote)
  • Conversion

    Series A Preferred Stock, par value $0.01

    2020-06-1523,8710 total(indirect: See footnote)
    Common Stock (41,535 underlying)
Transactions
  • Conversion

    Series A Preferred Stock, par value $0.01

    2020-06-1675,6880 total(indirect: See footnote)
    Common Stock (131,697 underlying)
  • Conversion

    Series A Preferred Stock, par value $0.01

    2020-06-15168,1640 total(indirect: See footnote)
    Common Stock (292,605 underlying)
  • Conversion

    Common Stock, par value $0.0001

    2020-06-15+41,535211,291 total(indirect: See footnote)
  • Conversion

    Series A Preferred Stock, par value $0.01

    2020-06-1523,8710 total(indirect: See footnote)
    Common Stock (41,535 underlying)
  • Conversion

    Common Stock, par value $0.0001

    2020-06-15+292,605292,605 total(indirect: See footnote)
  • Conversion

    Common Stock, par value $0.0001

    2020-06-15+131,697131,697 total(indirect: See footnote)
Footnotes (7)
  • [F1]These securities are directly held by Health Wildcatters Fund II, LLC ("HWF II"). Carl D. Soderstrom and Clay M. Heighten, M.D. are the managing members of Green Park & Golf Ventures, LLC ("GPG"), which is the managing member of Health Wildcatters, LLC ("HW"), which is the managing member of HWF II. Therefore, Carl D. Soderstrom, Clay M. Heighten, M.D., GPG, and HW may be deemed to beneficially own these securities.
  • [F2]These securities are directly held by GPG LPI Investment, LLC ("GPG LPI"). Carl D. Soderstrom and Clay M. Heighten, M.D. are the managing members of GPG, which is the managing member GPG LPI. Therefore, Carl D. Soderstrom, Clay M. Heighten, M.D., and GPG may be deemed to beneficially own these securities.
  • [F3]These securities are directly held by Lantern 3-19 Investment, LLC ("Lantern 3-19"). Carl D. Soderstrom, Clay M. Heighten, M.D., and Gilbert G. Garcia II are the managing members of Green Park & Golf Ventures II, LLC ("GPG II"), which is the managing member Lantern 3-19. Therefore, Carl D. Soderstrom, Clay M. Heighten, M.D., Gilbert G. Garcia II, and GPG II may be deemed to beneficially own these securities.
  • [F4]In connection with the Issuer's initial public offering, which commenced on June 10, 2020 and closed on June 15, 2020 (the "Initial Public Offering"), the Issuer effected a 1.74-for-1 stock split on its outstanding common stock, par value $0.0001 (the "Common Stock"), which was made effective immediately prior to the closing of the Issuer's Initial Public Offering (the "Stock Split"). The share amounts set forth in this column reflect the Stock Split.
  • [F5]In connection with the Initial Public Offering, 23,871 shares of the Issuer's Series A Preferred Stock, par value $0.01 ("Series A Preferred Stock"), directly held by HWF II, which had no expiration date, were automatically converted into 41,535 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering.
  • [F6]In connection with the Initial Public Offering, 168,164 shares of Series A Preferred Stock directly held by GPG LPI, which had no expiration date, were automatically converted into 292,605 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering.
  • [F7]In connection with the Initial Public Offering, approximately 75,688 shares of Series A Preferred Stock directly held by Lantern 3-19, which had no expiration date, were automatically converted into 131,697 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering.

Issuer

Lantern Pharma Inc.

CIK 0001763950

Entity typeother
IncorporatedTX

Related Parties

1
  • filerCIK 0001782733

Filing Metadata

Form type
4
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 5:35 PM ET
Size
31.5 KB